Skip to content

Effectiveness and safety of Picosecond laser for the treatment of dark lips, A pilot study

Effectiveness and safety of Picosecond laser for the treatment of dark lips, A pilot study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20201208001
Enrollment
24
Registered
2020-12-08
Start date
2020-03-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dark lip

Interventions

Picosecond 532 nm Nd:YAG&#44
Zoom HP Endpoint: Greyish to immediate whitening
Experimental Device
Picosecond 532 nm Nd:YAG by PicoWay®&#44
Syneron Candela&#44

Sponsors

Institute of Dermatology, Department of medical services
Lead Sponsor
Ministry of public health
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Age over 18 year-old 2.Fitzpatrick skin types IV-V 3.Able to attend every appointment assigned 4.Willing to participate in the study and signed the inform consent

Exclusion criteria

Exclusion criteria: 1.Presence of disease or condition such as fixed drug eruption, Pigmented contact dermatitis, discoid lupus erythematosus of the lips, Lichen planus of the lips, Labial lentigines, Peutz-Jegher syndrome, Addison’s syndrome 2.Pregnancy or lactation 3.Previously treated with energy base devices within 3 months 4.Previously treated with topical bleaching agents within 1 month 5.Active skin infection or dermatitis around the treated area 6.History of tattooing with pink or red color 7.Current smoking 8.Systemic retinoid within the past 6 months 9.Heavy sun exposure 10.Currently on systemic treatment: Hydroxychloroquine, Clofazimine, Zidovudine, Minocycline

Design outcomes

Primary

MeasureTime frame
Percent change in melanin index Week 0, week 4, week 8, week 12, week 24 Mexameter ®MX 18 spectrophotometer

Secondary

MeasureTime frame
Improvement scale week 4, week 8, week 12, week 24 Rating scale by blinded dermatologists,Patient satisfaction Week 24 Patient satisfaction rating scale,Adverse effects Week 0, week 4, week 8, week 12, week 24 Evaluated from patients and attending dermatologists

Countries

Thailand

Contacts

Public ContactTanaporn Borriboon

Institute of Dermatology

maikitty_bm@hotmail.com0850562424

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026